Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2003
12/31/2003WO2003075839A3 Methods of inducing terminal differentiation
12/31/2003WO2003074567A3 Internalizing anti-cd74 antibodies and methods of use
12/31/2003WO2003073999A3 Pini-modulating compounds and methods of use thereof
12/31/2003WO2003073918A3 Prevention of recurrence and metastasis of cancer
12/31/2003WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/31/2003WO2003072036A3 Treatment methods using anti-cd22 antibodies
12/31/2003WO2003068939A3 Cks1 INHIBITORS
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
12/31/2003WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003WO2003061621A3 Dermal application system for aminolevulinic acid-derivatives
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003057203A3 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003047606A3 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
12/31/2003WO2003045997A3 Fusion proteins containing tlp peptides
12/31/2003WO2003039486A3 Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies
12/31/2003WO2003035004A9 Immunotherapy for reversing immune suppression
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002070068A3 Lipoxin analogs as novel inhibitors of angiogenesis
12/31/2003WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization
12/31/2003WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/31/2003WO2002055075A3 Compounds and methods for regulating cell differentiation
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002047706A3 Selective cox-2 inhibition from plant extracts
12/31/2003WO2002042325A3 Cyp1b1 nucleic acids and methods of use
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002038143A3 Enhanced efficacy and safety of genotoxic therapy by p38 mapk modulation
12/31/2003WO2002031198A3 Cancer-linked genes as targets for chemotherapy
12/31/2003CN1464908A Multivalent antibodies and uses therefor
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1464068A Human brain tissue specificity molecular marker LRRC4
12/31/2003CN1464058A Tumor-repressed fusion protein, its encoding gene and use thereof
12/31/2003CN1464051A Herpesvirus thymine deoxyriboside kinase mutant and use thereof
12/31/2003CN1463980A Process for preparing panaxoside Rk1 and Rg5 by by panaxadiol type saponins acid hydrolysis
12/31/2003CN1463975A Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof
12/31/2003CN1463973A Novel anticancer plants extract, process of extraction and analogue thereof
12/31/2003CN1463748A A novel highly effective immunologic adjuvant originated from plants, method for making the same and use thereof
12/31/2003CN1463737A A fatty acid synthetase depressant, method for preparing same and use thereof
12/31/2003CN1463731A Medicament for treating pulmonary neoplasm, asthma and trachitis and method for making same
12/31/2003CN1463726A Externally applied traditional Chinese medicine for treating cancer and ache
12/31/2003CN1463722A A method for treating cancer and ache
12/31/2003CN1463701A Novel use of biphenyldicarboxylate as tumour multi-drug resistance inversion agent
12/31/2003CN1463610A Process for making liquorice tea
12/31/2003CN1132836C 各种片螺素化合物和类似物的合成及中间体 And various synthetic intermediates lamellarin compounds and the like
12/31/2003CN1132828C O-substd. hydroxy coumaranone derivs as antineoplastic and antitransfer agent
12/31/2003CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound
12/31/2003CN1132623C Compound Chinese medicine prepn. containing Jisongrong and Its prepn process
12/31/2003CN1132620C Aseptic 'Shenmai' powder for injection and its preparing process
12/31/2003CN1132586C Immunomodulating compositions from bile
12/31/2003CN1132585C Water soluble medical chitose preparation and its preparation
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CN1132557C 靶向局部治疗疾病的装置 Targeting apparatus topical treatment of diseases
12/31/2003CA2499709A1 Method for diagnosis of colorectal tumors
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2490704A1 Process for producing block copolymer/drug composite
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490423A1 Buffered formulations for concentrating antibodies and methods of use thereof
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490354A1 Drug transport and delivery system
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2489947A1 Treatment of human multiple myeloma by curcumin
12/31/2003CA2489847A1 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
12/31/2003CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003CA2489614A1 Oral preventive or therapeutic agent for skin damage containing diacylglyceryl ether
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2488942A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670456 Actinium-225 complexes and conjugates for targeted radiotherapy
12/30/2003US6670452 Non-naturally occurring lipoprotein particle
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670392 Administering vitamin e and selenium, or compound thereof
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670384 Methods of administering epothilone analogs for the treatment of cancer
12/30/2003US6670373 Compounds and method for inhibiting MRP1
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670368 Pyrimidine compounds with pharmaceutical activity
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670365 Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
12/30/2003US6670361 Anticancer agents
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003US6670353 Oxime-group containing oestrone sulphatase inhibitors
12/30/2003US6670350 Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same
12/30/2003US6670348 Antitumor geldanamycins
1 ... 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 ... 2211